Latest: FDA Approves New Biosimilar for Oncology Treatment

Electronic Health Record Study Finds No Significant Cardiovascular Risk With Triptan Use for Migraine

0 Mins
A recent study reassured that triptans may be safe for migraine treatment, emphasizing the need for individualized assessments of cardiovascular risks.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago